Virology

A topic in the Science corpus, drawn from 590 papers.

Trusted voices in Virology

Ordered by the trust Virology's own network concentrates on each researcher, most first.

  1. Marianne K. Soisalo — trusted by 14 researchers here
  2. David Posada — trusted by 11 researchers here
  3. S. Cavalcanti — trusted by 13 researchers here
  4. Yash Sharma — trusted by 14 researchers here
  5. P. Racey — trusted by 9 researchers here
  6. Jinfeng Yi — trusted by 13 researchers here
  7. Huan Zhang — trusted by 13 researchers here
  8. Pin-Yu Chen — trusted by 13 researchers here
  9. Cho-Jui Hsieh — trusted by 13 researchers here
  10. Alan S. Perelson — trusted by 5 researchers here
  11. Garrett M. Morris — trusted by 9 researchers here
  12. Philippe Lemey — trusted by 7 researchers here

Most-cited papers in Virology

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility (2009) — 23,062 citations
  2. Prevention of HIV-1 Infection with Early Antiretroviral Therapy (2011, Journal of family planning and reproductive health care) — 6,985 citations
  3. Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons (2010) — 4,949 citations
  4. Toxoplasma gondii: from animals to humans. (2000, International Journal of Parasitology) — 3,570 citations
  5. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. (2009, New England Journal of Medicine) — 3,102 citations
  6. Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women (2012, New England Journal of Medicine) — 3,037 citations
  7. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression (2006, Nature) — 2,853 citations
  8. Updated research nosology for HIV-associated neurocognitive disorders (2007, Neurology) — 2,610 citations
  9. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. (2000, Cell) — 2,590 citations
  10. Antibody neutralization and escape by HIV-1 (2003, Nature) — 2,588 citations
  11. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. (2000, New England Journal of Medicine) — 2,572 citations
  12. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection (2015, New England Journal of Medicine) — 2,567 citations
  13. Microbial translocation is a cause of systemic immune activation in chronic HIV infection (2006, Retrovirology) — 2,337 citations
  14. ZOO: Zeroth Order Optimization Based Black-box Attacks to Deep Neural Networks without Training Substitute Models (2017) — 2,214 citations
  15. Not so different after all: a comparison of methods for detecting amino acid sites under selection. (2005, Molecular biology and evolution) — 2,181 citations
  16. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. (2007, The Lancet) — 2,114 citations
  17. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. (2009, The Lancet) — 2,105 citations
  18. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (2008, Proceedings of the National Academy of Sciences of the United States of America) — 1,996 citations
  19. CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract (2004, Journal of Experimental Medicine) — 1,978 citations
  20. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. (2006, Blood) — 1,974 citations
  21. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu (2008, Nature) — 1,961 citations
  22. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys (2004, Nature) — 1,933 citations
  23. HIV-1 integration in the human genome favors active genes and local hotspots. (2002, Cell) — 1,921 citations
  24. Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients (2016, Medicine) — 1,911 citations
  25. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. (2011, Clinical Infectious Diseases) — 1,885 citations
  26. CD4+ count-guided interruption of antiretroviral treatment. (2006, New England Journal of Medicine) — 1,879 citations
  27. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (2010, Science) — 1,825 citations
  28. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target (2009, Science) — 1,821 citations
  29. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial (2008, The Lancet) — 1,795 citations
  30. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. (2009, New England Journal of Medicine) — 1,771 citations
  31. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial (2016, The Lancet) — 1,757 citations
  32. Bayesian Phylogeography Finds Its Roots (2009, PLoS Comput. Biol.) — 1,745 citations
  33. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (2012, New England Journal of Medicine) — 1,721 citations
  34. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation (2009, Nature Medicine) — 1,721 citations
  35. Interaction of silver nanoparticles with HIV-1 (2005, Journal of Nanobiotechnology) — 1,714 citations
  36. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy (2002, Antimicrobial Agents and Chemotherapy) — 1,677 citations
  37. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells (2003, Nature Medicine) — 1,661 citations
  38. Epidemiology of and Diagnostic Strategies for Toxoplasmosis (2012, Clinical Microbiology Reviews) — 1,658 citations
  39. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (2002, The Lancet) — 1,651 citations
  40. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction (2006, Nature Medicine) — 1,643 citations
  41. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection (2008, PLoS Medicine) — 1,638 citations
  42. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. (2022, New England Journal of Medicine) — 1,636 citations
  43. The changing epidemiology of human monkeypox—A potential threat? A systematic review (2021, medRxiv) — 1,581 citations
  44. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts (2003, Nature) — 1,578 citations
  45. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors (2010, Journal of Neurovirology) — 1,551 citations
  46. Broad neutralization coverage of HIV by multiple highly potent antibodies (2011, Nature) — 1,548 citations
  47. Efficient initiation of HCV RNA replication in cell culture. (2000, Science) — 1,529 citations
  48. Estimating the Global Burden of Endemic Canine Rabies (2015, PLoS Neglected Tropical Diseases) — 1,529 citations
  49. SAMHD1 is the dendritic– and myeloid–cell–specific HIV–1 restriction factor counteracted by Vpx (2011, Nature) — 1,526 citations
  50. Microbial translocation is a cause of systemic immune activation in chronic HIV infection (2006, Nature Medicine) — 1,508 citations

Most active researchers

By papers in this topic: a volume measure, not trust.